Report Detail

Medical Devices United States Inhalation Drug Delivery Devices Market Report 2017

  • RnM1182814
  • |
  • 19 April, 2017
  • |
  • Global
  • |
  • 117 pages
  • |
  • QYResearch
  • |
  • Medical Devices

United States Inhalation Drug Delivery Devices Market Report 2017

Table of Contents

    United States Inhalation Drug Delivery Devices Market Report 2017

      1 Inhalation Drug Delivery Devices Overview

      • 1.1 Product Overview and Scope of Inhalation Drug Delivery Devices
      • 1.2 Classification of Inhalation Drug Delivery Devices by Product Category
        • 1.2.1 United States Inhalation Drug Delivery Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
        • 1.2.2 United States Inhalation Drug Delivery Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        • 1.2.3 Nebulizers
        • 1.2.4 Dry Powder Inhaler (DPI)
        • 1.2.5 Metered Dose Inhaler (MDI)
      • 1.3 United States Inhalation Drug Delivery Devices Market by Application/End Users
        • 1.3.1 United States Inhalation Drug Delivery Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        • 1.3.2 COPD (Chronic Obstructive Pulmonary Disease)
        • 1.3.3 Asthma
      • 1.4 United States Inhalation Drug Delivery Devices Market by Region
        • 1.4.1 United States Inhalation Drug Delivery Devices Market Size (Value) Comparison by Region (2012-2022)
        • 1.4.2 The West Inhalation Drug Delivery Devices Status and Prospect (2012-2022)
        • 1.4.3 Southwest Inhalation Drug Delivery Devices Status and Prospect (2012-2022)
        • 1.4.4 The Middle Atlantic Inhalation Drug Delivery Devices Status and Prospect (2012-2022)
        • 1.4.5 New England Inhalation Drug Delivery Devices Status and Prospect (2012-2022)
        • 1.4.6 The South Inhalation Drug Delivery Devices Status and Prospect (2012-2022)
        • 1.4.7 The Midwest Inhalation Drug Delivery Devices Status and Prospect (2012-2022)
      • 1.5 United States Market Size (Value and Volume) of Inhalation Drug Delivery Devices (2012-2022)
        • 1.5.1 United States Inhalation Drug Delivery Devices Sales and Growth Rate (2012-2022)
        • 1.5.2 United States Inhalation Drug Delivery Devices Revenue and Growth Rate (2012-2022)

      2 United States Inhalation Drug Delivery Devices Market Competition by Players/Suppliers

      • 2.1 United States Inhalation Drug Delivery Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
      • 2.2 United States Inhalation Drug Delivery Devices Revenue and Share by Players/Suppliers (2012-2017)
      • 2.3 United States Inhalation Drug Delivery Devices Average Price by Players/Suppliers (2012-2017)
      • 2.4 United States Inhalation Drug Delivery Devices Market Competitive Situation and Trends
        • 2.4.1 United States Inhalation Drug Delivery Devices Market Concentration Rate
        • 2.4.2 United States Inhalation Drug Delivery Devices Market Share of Top 3 and Top 5 Players/Suppliers
        • 2.4.3 Mergers & Acquisitions, Expansion in United States Market
      • 2.5 United States Players/Suppliers Inhalation Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type

      3 United States Inhalation Drug Delivery Devices Sales (Volume) and Revenue (Value) by Region (2012-2017)

      • 3.1 United States Inhalation Drug Delivery Devices Sales and Market Share by Region (2012-2017)
      • 3.2 United States Inhalation Drug Delivery Devices Revenue and Market Share by Region (2012-2017)
      • 3.3 United States Inhalation Drug Delivery Devices Price by Region (2012-2017)

      4 United States Inhalation Drug Delivery Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

      • 4.1 United States Inhalation Drug Delivery Devices Sales and Market Share by Type (Product Category) (2012-2017)
      • 4.2 United States Inhalation Drug Delivery Devices Revenue and Market Share by Type (2012-2017)
      • 4.3 United States Inhalation Drug Delivery Devices Price by Type (2012-2017)
      • 4.4 United States Inhalation Drug Delivery Devices Sales Growth Rate by Type (2012-2017)

      5 United States Inhalation Drug Delivery Devices Sales (Volume) by Application (2012-2017)

      • 5.1 United States Inhalation Drug Delivery Devices Sales and Market Share by Application (2012-2017)
      • 5.2 United States Inhalation Drug Delivery Devices Sales Growth Rate by Application (2012-2017)
      • 5.3 Market Drivers and Opportunities

      6 United States Inhalation Drug Delivery Devices Players/Suppliers Profiles and Sales Data

      • 6.1 GSK
        • 6.1.1 Company Basic Information, Manufacturing Base and Competitors
        • 6.1.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.1.2.1 Product A
          • 6.1.2.2 Product B
        • 6.1.3 GSK Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.1.4 Main Business/Business Overview
      • 6.2 3M
        • 6.2.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.2.2.1 Product A
          • 6.2.2.2 Product B
        • 6.2.3 3M Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.2.4 Main Business/Business Overview
      • 6.3 AstraZeneca
        • 6.3.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.3.2.1 Product A
          • 6.3.2.2 Product B
        • 6.3.3 AstraZeneca Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.3.4 Main Business/Business Overview
      • 6.4 Novartis
        • 6.4.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.4.2.1 Product A
          • 6.4.2.2 Product B
        • 6.4.3 Novartis Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.4.4 Main Business/Business Overview
      • 6.5 Aptar
        • 6.5.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.5.2.1 Product A
          • 6.5.2.2 Product B
        • 6.5.3 Aptar Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.5.4 Main Business/Business Overview
      • 6.6 Boehringer Ingelheim
        • 6.6.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.6.2.1 Product A
          • 6.6.2.2 Product B
        • 6.6.3 Boehringer Ingelheim Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.6.4 Main Business/Business Overview
      • 6.7 Chiesi Farmaceutici
        • 6.7.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.7.2.1 Product A
          • 6.7.2.2 Product B
        • 6.7.3 Chiesi Farmaceutici Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.7.4 Main Business/Business Overview
      • 6.8 Omron Healthcare
        • 6.8.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.8.2.1 Product A
          • 6.8.2.2 Product B
        • 6.8.3 Omron Healthcare Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.8.4 Main Business/Business Overview
      • 6.9 Philips Respironics
        • 6.9.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.9.2.1 Product A
          • 6.9.2.2 Product B
        • 6.9.3 Philips Respironics Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.9.4 Main Business/Business Overview
      • 6.10 PARI Respiratory
        • 6.10.2 Inhalation Drug Delivery Devices Product Category, Application and Specification
          • 6.10.2.1 Product A
          • 6.10.2.2 Product B
        • 6.10.3 PARI Respiratory Inhalation Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        • 6.10.4 Main Business/Business Overview
      • 6.11 Skyepharma
      • 6.12 CareFusion
      • 6.13 Shanghai HuaRui
      • 6.14 Taian Character
      • 6.15 Aptar China
      • 6.16 Chia Tai Tianqing
      • 6.17 Allergan
      • 6.18 DJO Global
      • 6.19 CareFusion
      • 6.20 DeVilbiss Healthcare
      • 6.21 GlaxoSmithKline
      • 6.22 Johnson & Johnson
      • 6.23 Monaghan Medical
      • 6.24 Mylan
      • 6.25 Hisamitsu Pharmaceutical
      • 6.26 Philips Healthcare
      • 6.27 Salter Labs
      • 6.28 Smiths Medical
      • 6.29 Teikoku Pharma
      • 6.30 Teleflex Medical

      7 Inhalation Drug Delivery Devices Manufacturing Cost Analysis

      • 7.1 Inhalation Drug Delivery Devices Key Raw Materials Analysis
        • 7.1.1 Key Raw Materials
        • 7.1.2 Price Trend of Key Raw Materials
        • 7.1.3 Key Suppliers of Raw Materials
        • 7.1.4 Market Concentration Rate of Raw Materials
      • 7.2 Proportion of Manufacturing Cost Structure
        • 7.2.1 Raw Materials
        • 7.2.2 Labor Cost
        • 7.2.3 Manufacturing Expenses
      • 7.3 Manufacturing Process Analysis of Inhalation Drug Delivery Devices

      8 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 8.1 Inhalation Drug Delivery Devices Industrial Chain Analysis
      • 8.2 Upstream Raw Materials Sourcing
      • 8.3 Raw Materials Sources of Inhalation Drug Delivery Devices Major Manufacturers in 2016
      • 8.4 Downstream Buyers

      9 Marketing Strategy Analysis, Distributors/Traders

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
        • 9.1.3 Marketing Channel Development Trend
      • 9.2 Market Positioning
        • 9.2.1 Pricing Strategy
        • 9.2.2 Brand Strategy
        • 9.2.3 Target Client
      • 9.3 Distributors/Traders List

      10 Market Effect Factors Analysis

      • 10.1 Technology Progress/Risk
        • 10.1.1 Substitutes Threat
        • 10.1.2 Technology Progress in Related Industry
      • 10.2 Consumer Needs/Customer Preference Change
      • 10.3 Economic/Political Environmental Change

      11 United States Inhalation Drug Delivery Devices Market Size (Value and Volume) Forecast (2017-2022)

      • 11.1 United States Inhalation Drug Delivery Devices Sales Volume, Revenue Forecast (2017-2022)
      • 11.2 United States Inhalation Drug Delivery Devices Sales Volume Forecast by Type (2017-2022)
      • 11.3 United States Inhalation Drug Delivery Devices Sales Volume Forecast by Application (2017-2022)
      • 11.4 United States Inhalation Drug Delivery Devices Sales Volume Forecast by Region (2017-2022)

      12 Research Findings and Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources

        In this report, the United States Inhalation Drug Delivery Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

        Geographically, this report splits the United States market into seven regions:
        The West
        Southwest
        The Middle Atlantic
        New England
        The South
        The Midwest
        with sales (volume), revenue (value), market share and growth rate of Inhalation Drug Delivery Devices in these regions, from 2012 to 2022 (forecast).

        United States Inhalation Drug Delivery Devices market competition by top manufacturers/players, with Inhalation Drug Delivery Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
        GSK
        3M
        AstraZeneca
        Novartis
        Aptar
        Boehringer Ingelheim
        Chiesi Farmaceutici
        Omron Healthcare
        Philips Respironics
        PARI Respiratory
        Skyepharma
        CareFusion
        Shanghai HuaRui
        Taian Character
        Aptar China
        Chia Tai Tianqing
        Allergan
        DJO Global
        CareFusion
        DeVilbiss Healthcare
        GlaxoSmithKline
        Johnson & Johnson
        Monaghan Medical
        Mylan
        Hisamitsu Pharmaceutical
        Philips Healthcare
        Salter Labs
        Smiths Medical
        Teikoku Pharma
        Teleflex Medical

        On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
        Nebulizers
        Dry Powder Inhaler (DPI)
        Metered Dose Inhaler (MDI)
        On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Inhalation Drug Delivery Devices for each application, including
        COPD (Chronic Obstructive Pulmonary Disease)
        Asthma

        If you have any special requirements, please let us know and we will offer you the report as you want.



        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,800.00
        $7,600.00
        3,120.56
        6,241.12
        3,426.69
        6,853.38
        404,684.80
        809,369.60
        272,615.42
        545,230.84
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report